hit counter

Berberine for Alzheimer’s Disease Treatment: Mechanisms & Efficacy (2023 Review)

In the quest for more effective treatments for Alzheimer’s Disease (AD), berberine, a bioactive compound derived from traditional Chinese medicine, has emerged as a promising candidate. Recent preclinical studies have showcased its potential to combat the debilitating effects of AD, with evidence pointing towards its ability to improve cognitive functions, reduce hallmark AD pathologies such …

Read more

Psychedelics vs. Epilepsy & Seizures: Effective Treatment or Exacerbation? (2023 Review)

Psychedelic compounds, long associated with the fringes of medicine and spirituality, are now at the forefront of a radical shift in neurology and psychiatry. Decades of clinical trials have begun to unravel the therapeutic potentials of these substances, revealing promising outcomes in the treatment of various psychiatric disorders. However, a notable gap in this burgeoning …

Read more

Genetics of Common Executive Function (Cognition) from UK Biobank Data (2023 Study)

Executive functioning (EF) is a cognitive cornerstone essential for goal-directed behaviors and complex thinking. Recent research leveraging the massive UK Biobank dataset has shed new light on the genetic underpinnings of EF, revealing its distinct genetic profile from intelligence (IQ) and its intricate link with psychiatric disorders. This study underscores the importance of EF in …

Read more

Ultra-Processed Foods (UPF) Linked to Increased Alzheimer’s Disease Risk (2023 Review)

In the modern dietary landscape, ultra-processed foods (UPFs) have become a staple in many diets, celebrated for their convenience and palatability. However, emerging research reveals a concerning association between UPF consumption and increased risk of Alzheimer’s disease (AD), a leading cause of dementia. Highlights: Strong Link: Recent systematic reviews indicate a strong link between high …

Read more

CNQX as a Potential Drug Addiction Treatment via AMPA & Kainate Receptors (Glutamate) (2023 Study)

The journey to overcome addiction is fraught with challenges, not least due to the limited options available for pharmacological intervention. In recent research, the focus has shifted toward understanding the role of glutamate, a key neurotransmitter in the brain, in the development and persistence of addictive behaviors. One compound, CNQX, which antagonizes certain glutamate receptors, …

Read more

T2943 Treats Depression via Epigenetics: HDAC5 Inibitor in Hippocampus (2024 Study)

Depression remains one of the most pervasive and challenging mental health conditions, affecting millions worldwide with a significant number not responding to traditional treatments. Emerging research underscores the role of histone modifications in depression, pointing towards epigenetic mechanisms as potential targets for novel antidepressants. Specifically, a compound known as T2943 (a histone deacetylase-5 (HDAC5) inhibitor), …

Read more

Caffeine & Depression: Lower Risk with >90 mg per Day in Adults (2022 Study)

In the quest to understand the intricate links between our dietary habits and mental health, a recent study leveraging data from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 offers new insights into how caffeine consumption correlates with depression. This comprehensive analysis reveals that moderate caffeine intake might have a protective effect against depression, …

Read more